IYH (IYH)

This article compares two healthcare ETFs, the VanEck Pharmaceutical ETF (PPH) and the iShares U.S. Healthcare ETF (IYH), to determine which is a better investment. PPH offers a more concentrated bet on pharmaceutical companies with a higher dividend yield and better five-year returns, while IYH provides broader exposure across the healthcare sector with lower volatility. The choice depends on an investor's willingness to take on concentration risk versus desiring greater diversification.

This article compares two healthcare ETFs, Fidelity MSCI Health Care Index ETF (FHLC) and iShares U.S. Healthcare ETF (IYH), to help investors decide which is the better buy. It highlights that FHLC offers a lower expense ratio and broader diversification, leading to better long-term performance despite similar top holdings and risk profiles. The article concludes that FHLC is the preferred choice due to its cost efficiency and consistent outperformance.

This article compares two prominent healthcare ETFs, State Street Health Care Select Sector SPDR ETF (XLV) and iShares U.S. Healthcare ETF (IYH), focusing on their cost, yield, and portfolio characteristics. XLV boasts a significantly lower expense ratio and higher dividend yield, while IYH offers broader market coverage. The analysis concludes that XLV is generally the more favorable option due to its lower fees, better historical performance, and higher dividend yield.

This article compares two prominent healthcare ETFs, State Street Health Care Select Sector SPDR ETF (XLV) and iShares U.S. Healthcare ETF (IYH), focusing on their cost structures, dividend yields, holdings, and performance. XLV is presented as the more affordable option with a lower expense ratio and higher dividend yield, despite IYH offering broader market coverage. The analysis suggests XLV is generally the preferred choice due to its cost-effectiveness and slightly better historical performance.

This article compares two healthcare ETFs, PJP and IYH, to help investors decide which is a better buy. It details their expense ratios, dividend yields, returns, and holdings, highlighting PJP's concentrated focus on pharmaceuticals and IYH's broader diversification. The choice between them depends on an investor's preference for concentration risk versus steady, lower-cost exposure to the healthcare sector.